🔥 Thursday 20 November 2025 Thu, 20 Nov 2025
79 Big Stories
TPG Telecom Unveils $138M Retail Reinvestment Plan to Strengthen Balance Sheet
TPG Telecom has launched a $138 million Retail Reinvestment Plan, allowing eligible shareholders to reinvest proceeds from a $3 billion capital return. This initiative complements a $300 million institutional plan, aiming to reduce debt and enhance shareholder value.
20 Nov
Sophie Babbage
Turners Automotive Group Drives Record 1H26 Profit Amid Market Headwinds
Turners Automotive Group has posted a resilient and record first-half result for FY26, with net profit before tax up 13% despite ongoing economic challenges. The company’s diversified model and strategic capital moves underpin its confident outlook.
20 Nov
Victor Sage
Turners Automotive Group Drives Record Profit Growth Amid Market Challenges
Turners Automotive Group has delivered a record first-half profit for FY26, driven by strong growth in its Finance and Insurance divisions despite ongoing supply constraints in the used vehicle market. The company also raised its interim dividend, signalling confidence in its diversified business model and capital management strategy.
20 Nov
Victor Sage
AFT Pharmaceuticals Accelerates Global Growth with 33% Revenue Surge in 1H FY26
AFT Pharmaceuticals reports a robust 33% revenue increase in the first half of FY26, driven by strong ANZ market performance and expanding international presence. The company advances its R&D pipeline and targets NZ$300 million revenue for FY27 amid strategic global expansion.
20 Nov
Ada Torres
AFT Pharmaceuticals Accelerates Growth with 33% Revenue Surge and Global Expansion
AFT Pharmaceuticals delivered a robust first half for FY26, posting 33% revenue growth and a return to profitability, driven by strong Australian sales and recovery in Asia and international markets. The company is advancing its global footprint and R&D pipeline, positioning for sustained growth.
20 Nov
Victor Sage
AFT Pharmaceuticals Powers Ahead with 33% Revenue Surge and R&D Breakthroughs
AFT Pharmaceuticals has reported a robust first half of FY26, posting a 33% revenue increase to a record $114.9 million and returning to profitability amid strong growth in Australia and international markets. The company’s advancing R&D pipeline and strategic licensing deals position it well for ambitious FY27 targets.
20 Nov
Victor Sage
a2 Milk Company Boosts FY26 Revenue Forecast on Strong IMF Sales
The a2 Milk Company has raised its FY26 revenue guidance, citing stronger-than-expected performance in key product categories and favourable currency movements. The company anticipates solid earnings growth and robust cash flow conversion.
20 Nov
Victor Sage